These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 6351033

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA.
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lithium and carbamazepine therapy in a patient with manic depressive illness: clinical effects, interactions and side effects.
    Klein EM.
    Isr J Psychiatry Relat Sci; 1987; 24(4):295-8. PubMed ID: 3505519
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH, McNamara RK, Watterson JM, Watson DG.
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [Abstract] [Full Text] [Related]

  • 29. Dosing strategies and time course of response to antimanic drugs.
    Bowden CL.
    J Clin Psychiatry; 1996; 57 Suppl 13():4-9; discussion 10-2. PubMed ID: 8970500
    [Abstract] [Full Text] [Related]

  • 30. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD.
    Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.
    Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS.
    J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prophylactic efficacy of carbamazepine in manic-depressive illness.
    Post RM, Uhde TW, Ballenger JC, Squillace KM.
    Am J Psychiatry; 1983 Dec; 140(12):1602-4. PubMed ID: 6139957
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Selective response to the anticonvulsant carbamazepine in manic-depressive illness: a case study.
    Post RM, Berrettini W, Uhde TW, Kellner C.
    J Clin Psychopharmacol; 1984 Aug; 4(4):178-85. PubMed ID: 6432857
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Status of thymoleptics in the treatment of bipolar disorders].
    Sechter D.
    Encephale; 1996 Aug; 22(1):65-8. PubMed ID: 8681877
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.